Does inhibition of nuclear factor-kappaB activation improve the survival of rats with taurocholate pancreatitis?
Early blockage of NF-kappaB activation may be effective in reducing fatal outcome in severe acute pancreatitis.
MNCOP-B is an effective regimen in intermediate and high grade NHL and easily manageable in the out-patient clinic. The incidence of mucositis is sensibly reduced as compared to the parental regimen MACOP-B reported in the literature; this result allows the use of MNCOP-B in older patients.